BAJAJ BROKING
Mankind Pharma acquires Bharat Serums and Vaccines for ₹13,630 crore, enhancing its leadership in women's health and fertility drugs. Mankind Pharma’s share price rose by 1.81% to ₹2143.90, with a market cap close to ₹86,000 crore.
Mankind Pharma's share price today is set to be in the spotlight following the announcement of its acquisition of Bharat Serums and Vaccines (BSV) from Advent International. This move aims to strengthen Mankind Pharma's portfolio in high-entry barrier products and secure its leadership in women's health.
Mankind Pharma has signed a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines from Advent International, a leading global private equity investor, for an enterprise value of ₹13,630 crore, subject to closing adjustments.
The acquisition aligns with Mankind Pharma's strategy to strengthen its position in the women's health and fertility drug market.
The acquisition of BSV represents a significant milestone for Mankind Pharma. It positions the company as a market leader in the Indian women's health and fertility segment while providing access to high-entry barrier products in critical care.
BSV's established R&D technology platforms and robust branded product portfolio in women's health, fertility, and critical care further enhance Mankind Pharma's capabilities.
Following the acquisition announcement, Mankind Pharma share price rose by over 1.81%, settling at ₹2143.90 on Thursday. The company's market capitalization reached approximately ₹86,000 crore.
Mankind Pharma's stock has nearly doubled in value since its initial public offering (IPO) in May 2023, which raised ₹4,326.36 crore at an IPO price of ₹1,080 per share.
Rajeev Juneja, Vice-chairman and Managing Director of Mankind Pharma, highlighted the substantial opportunities and growth potential in the women's health and fertility segment, driven by structural tailwinds globally.
The acquisition of BSV is expected to propel Mankind Pharma's market leadership and enhance its growth prospects in the high-potential segments.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Gold Rate Today | 15 January 2025 | Gold Price in India
15 Jan, 2025 | 40 Min. read
Delhi Court Discharges JSW Steel in Corruption Case; HC Clears Monnet Takeover
15 Jan, 2025 | 2 Min. read
IRFC Emerges L1 Bidder to Finance ₹3,167 Crore for Banhardih Coal Block
15 Jan, 2025 | 2 Min. read
Cipla’s Tax Demand Reduced to ₹559.18 Crores After Revision
15 Jan, 2025 | 2 Min. read
Govt Plans 5-6% Hike in Highway Budget for FY26 After FY25 Slump
15 Jan, 2025 | 2 Min. read
Rikhav Securities IPO- Key Objective & Deep Analysis
15 Jan, 2025 | 5 Min. read
HCL Tech expands partnership with Microsoft to transform contact centres
14 Jan, 2025 | 2 Min. read
BEL secures new orders worth Rs 561 crore, boosting FY25 order book
14 Jan, 2025 | 2 Min. read
ITI Ltd secures Rs 64 crore contracts for Wi-Fi and CCTV systems
14 Jan, 2025 | 2 Min. read
JSW Energy secures LoI for 3.6 GW KSK Mahanadi power plant
14 Jan, 2025 | 2 Min. read
Biocon Biologics’ Johor Bahru Facility Receives FDA VAI Classification
13 Jan, 2025 | 2 Min. read
Interarch Secures ₹221 Crore Projects in Semiconductors & Energy Storage
13 Jan, 2025 | 2 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading